| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9822 |
| Human Intestinal Absorption | HIA+ | 0.9456 |
| Caco-2 Permeability | Caco2+ | 0.7066 |
| P-glycoprotein Substrate | Non-substrate | 0.8959 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9793 |
| Non-inhibitor | 0.9814 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9269 |
| Distribution |
| Subcellular localization | Lysosome | 0.4936 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8433 |
| CYP450 2D6 Substrate | Non-substrate | 0.7451 |
| CYP450 3A4 Substrate | Non-substrate | 0.7941 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7925 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8935 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9444 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9194 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9627 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9250 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9658 |
| Non-inhibitor | 0.9549 |
| AMES Toxicity | Non AMES toxic | 0.8722 |
| Carcinogens | Carcinogens | 0.7363 |
| Fish Toxicity | Low FHMT | 0.5779 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.6557 |
| Honey Bee Toxicity | High HBT | 0.8111 |
| Biodegradation | Not ready biodegradable | 0.5851 |
| Acute Oral Toxicity | III | 0.6819 |
| Carcinogenicity (Three-class) | Non-required | 0.4669 |